Home > Financial Ratios > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 583.51-91.805.4623.93404.51

What is the latest EBIT Growth ratio of BALAXI PHARMACEUTICALS ?

The latest EBIT Growth ratio of BALAXI PHARMACEUTICALS is 583.51 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025583.51
Mar2024-91.80
Mar20235.46
Mar202223.93
Mar2021404.51

How is EBIT Growth of BALAXI PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2025 583.51
Positive
Mar2024 -91.8
Negative
Mar2023 5.46
-77.18
Mar2022 23.93
-94.08
Mar2021 404.51 -

Other Financial Ratios of BALAXI PHARMACEUTICALS


Compare EBIT Growth ratio of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹231.0 Cr -2.6% -4.1% -53.6% Stock Analytics
ADANI ENTERPRISES ₹273,431.0 Cr -4.5% -6.8% -21.5% Stock Analytics
REDINGTON ₹22,499.5 Cr 15% 6.1% 49.6% Stock Analytics
LLOYDS ENTERPRISES ₹10,116.5 Cr -3.1% -3.9% 47.7% Stock Analytics
MMTC ₹9,921.0 Cr -4.9% -4.4% -17% Stock Analytics
HONASA CONSUMER ₹8,933.0 Cr -3.8% -7.2% -30% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-2.6%

-4.1%

-53.6%

SENSEX

-0.5%

2%

4.8%


You may also like the below Video Courses